Cargando…
Cardiac dysfunction and peri-weaning mortality in malonyl-coenzyme A decarboxylase (MCD) knockout mice as a consequence of restricting substrate plasticity
Inhibition of malonyl-coenzyme A decarboxylase (MCD) shifts metabolism from fatty acid towards glucose oxidation, which has therapeutic potential for obesity and myocardial ischemic injury. However, ~ 40% of patients with MCD deficiency are diagnosed with cardiomyopathy during infancy. AIM: To clari...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academic Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4169183/ https://www.ncbi.nlm.nih.gov/pubmed/25066696 http://dx.doi.org/10.1016/j.yjmcc.2014.07.008 |
_version_ | 1782335671559520256 |
---|---|
author | Aksentijević, Dunja McAndrew, Debra J. Karlstädt, Anja Zervou, Sevasti Sebag-Montefiore, Liam Cross, Rebecca Douglas, Gillian Regitz-Zagrosek, Vera Lopaschuk, Gary D. Neubauer, Stefan Lygate, Craig A. |
author_facet | Aksentijević, Dunja McAndrew, Debra J. Karlstädt, Anja Zervou, Sevasti Sebag-Montefiore, Liam Cross, Rebecca Douglas, Gillian Regitz-Zagrosek, Vera Lopaschuk, Gary D. Neubauer, Stefan Lygate, Craig A. |
author_sort | Aksentijević, Dunja |
collection | PubMed |
description | Inhibition of malonyl-coenzyme A decarboxylase (MCD) shifts metabolism from fatty acid towards glucose oxidation, which has therapeutic potential for obesity and myocardial ischemic injury. However, ~ 40% of patients with MCD deficiency are diagnosed with cardiomyopathy during infancy. AIM: To clarify the link between MCD deficiency and cardiac dysfunction in early life and to determine the contributing systemic and cardiac metabolic perturbations. METHODS AND RESULTS: MCD knockout mice ((−/−)) exhibited non-Mendelian genotype ratios (31% fewer MCD(−/−)) with deaths clustered around weaning. Immediately prior to weaning (18 days) MCD(−/−) mice had lower body weights, elevated body fat, hepatic steatosis and glycogen depletion compared to wild-type littermates. MCD(−/−) plasma was hyperketonemic, hyperlipidemic, had 60% lower lactate levels and markers of cellular damage were elevated. MCD(−/−) hearts exhibited hypertrophy, impaired ejection fraction and were energetically compromised (32% lower total adenine nucleotide pool). However differences between WT and MCD(−/−) converged with age, suggesting that, in surviving MCD(−/−) mice, early cardiac dysfunction resolves over time. These observations were corroborated by in silico modelling of cardiomyocyte metabolism, which indicated improvement of the MCD(−/−) metabolic phenotype and improved cardiac efficiency when switched from a high-fat diet (representative of suckling) to a standard post-weaning diet, independent of any developmental changes. CONCLUSIONS: MCD(−/−) mice consistently exhibited cardiac dysfunction and severe metabolic perturbations while on a high-fat, low carbohydrate diet of maternal milk and these gradually resolved post-weaning. This suggests that dysfunction is a common feature of MCD deficiency during early development, but that severity is dependent on composition of dietary substrates. |
format | Online Article Text |
id | pubmed-4169183 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Academic Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-41691832014-10-01 Cardiac dysfunction and peri-weaning mortality in malonyl-coenzyme A decarboxylase (MCD) knockout mice as a consequence of restricting substrate plasticity Aksentijević, Dunja McAndrew, Debra J. Karlstädt, Anja Zervou, Sevasti Sebag-Montefiore, Liam Cross, Rebecca Douglas, Gillian Regitz-Zagrosek, Vera Lopaschuk, Gary D. Neubauer, Stefan Lygate, Craig A. J Mol Cell Cardiol Original Article Inhibition of malonyl-coenzyme A decarboxylase (MCD) shifts metabolism from fatty acid towards glucose oxidation, which has therapeutic potential for obesity and myocardial ischemic injury. However, ~ 40% of patients with MCD deficiency are diagnosed with cardiomyopathy during infancy. AIM: To clarify the link between MCD deficiency and cardiac dysfunction in early life and to determine the contributing systemic and cardiac metabolic perturbations. METHODS AND RESULTS: MCD knockout mice ((−/−)) exhibited non-Mendelian genotype ratios (31% fewer MCD(−/−)) with deaths clustered around weaning. Immediately prior to weaning (18 days) MCD(−/−) mice had lower body weights, elevated body fat, hepatic steatosis and glycogen depletion compared to wild-type littermates. MCD(−/−) plasma was hyperketonemic, hyperlipidemic, had 60% lower lactate levels and markers of cellular damage were elevated. MCD(−/−) hearts exhibited hypertrophy, impaired ejection fraction and were energetically compromised (32% lower total adenine nucleotide pool). However differences between WT and MCD(−/−) converged with age, suggesting that, in surviving MCD(−/−) mice, early cardiac dysfunction resolves over time. These observations were corroborated by in silico modelling of cardiomyocyte metabolism, which indicated improvement of the MCD(−/−) metabolic phenotype and improved cardiac efficiency when switched from a high-fat diet (representative of suckling) to a standard post-weaning diet, independent of any developmental changes. CONCLUSIONS: MCD(−/−) mice consistently exhibited cardiac dysfunction and severe metabolic perturbations while on a high-fat, low carbohydrate diet of maternal milk and these gradually resolved post-weaning. This suggests that dysfunction is a common feature of MCD deficiency during early development, but that severity is dependent on composition of dietary substrates. Academic Press 2014-10 /pmc/articles/PMC4169183/ /pubmed/25066696 http://dx.doi.org/10.1016/j.yjmcc.2014.07.008 Text en © 2014 The Authors. Published by Elsevier Ltd. https://creativecommons.org/licenses/by/3.0/This work is licensed under a Creative Commons Attribution 3.0 Unported License (https://creativecommons.org/licenses/by/3.0/) . |
spellingShingle | Original Article Aksentijević, Dunja McAndrew, Debra J. Karlstädt, Anja Zervou, Sevasti Sebag-Montefiore, Liam Cross, Rebecca Douglas, Gillian Regitz-Zagrosek, Vera Lopaschuk, Gary D. Neubauer, Stefan Lygate, Craig A. Cardiac dysfunction and peri-weaning mortality in malonyl-coenzyme A decarboxylase (MCD) knockout mice as a consequence of restricting substrate plasticity |
title | Cardiac dysfunction and peri-weaning mortality in malonyl-coenzyme A decarboxylase (MCD) knockout mice as a consequence of restricting substrate plasticity |
title_full | Cardiac dysfunction and peri-weaning mortality in malonyl-coenzyme A decarboxylase (MCD) knockout mice as a consequence of restricting substrate plasticity |
title_fullStr | Cardiac dysfunction and peri-weaning mortality in malonyl-coenzyme A decarboxylase (MCD) knockout mice as a consequence of restricting substrate plasticity |
title_full_unstemmed | Cardiac dysfunction and peri-weaning mortality in malonyl-coenzyme A decarboxylase (MCD) knockout mice as a consequence of restricting substrate plasticity |
title_short | Cardiac dysfunction and peri-weaning mortality in malonyl-coenzyme A decarboxylase (MCD) knockout mice as a consequence of restricting substrate plasticity |
title_sort | cardiac dysfunction and peri-weaning mortality in malonyl-coenzyme a decarboxylase (mcd) knockout mice as a consequence of restricting substrate plasticity |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4169183/ https://www.ncbi.nlm.nih.gov/pubmed/25066696 http://dx.doi.org/10.1016/j.yjmcc.2014.07.008 |
work_keys_str_mv | AT aksentijevicdunja cardiacdysfunctionandperiweaningmortalityinmalonylcoenzymeadecarboxylasemcdknockoutmiceasaconsequenceofrestrictingsubstrateplasticity AT mcandrewdebraj cardiacdysfunctionandperiweaningmortalityinmalonylcoenzymeadecarboxylasemcdknockoutmiceasaconsequenceofrestrictingsubstrateplasticity AT karlstadtanja cardiacdysfunctionandperiweaningmortalityinmalonylcoenzymeadecarboxylasemcdknockoutmiceasaconsequenceofrestrictingsubstrateplasticity AT zervousevasti cardiacdysfunctionandperiweaningmortalityinmalonylcoenzymeadecarboxylasemcdknockoutmiceasaconsequenceofrestrictingsubstrateplasticity AT sebagmontefioreliam cardiacdysfunctionandperiweaningmortalityinmalonylcoenzymeadecarboxylasemcdknockoutmiceasaconsequenceofrestrictingsubstrateplasticity AT crossrebecca cardiacdysfunctionandperiweaningmortalityinmalonylcoenzymeadecarboxylasemcdknockoutmiceasaconsequenceofrestrictingsubstrateplasticity AT douglasgillian cardiacdysfunctionandperiweaningmortalityinmalonylcoenzymeadecarboxylasemcdknockoutmiceasaconsequenceofrestrictingsubstrateplasticity AT regitzzagrosekvera cardiacdysfunctionandperiweaningmortalityinmalonylcoenzymeadecarboxylasemcdknockoutmiceasaconsequenceofrestrictingsubstrateplasticity AT lopaschukgaryd cardiacdysfunctionandperiweaningmortalityinmalonylcoenzymeadecarboxylasemcdknockoutmiceasaconsequenceofrestrictingsubstrateplasticity AT neubauerstefan cardiacdysfunctionandperiweaningmortalityinmalonylcoenzymeadecarboxylasemcdknockoutmiceasaconsequenceofrestrictingsubstrateplasticity AT lygatecraiga cardiacdysfunctionandperiweaningmortalityinmalonylcoenzymeadecarboxylasemcdknockoutmiceasaconsequenceofrestrictingsubstrateplasticity |